These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 18243910)
41. Conflicts of interest and authorship of industry-sponsored publications. Paul C; Tauber M Br J Dermatol; 2017 Jan; 176(1):200-203. PubMed ID: 28098381 [No Abstract] [Full Text] [Related]
42. [Is clinical research in Denmark directed by drug industry?]. Jacobsen IA Ugeskr Laeger; 2004 Jun; 166(24):2367-8. PubMed ID: 15281581 [No Abstract] [Full Text] [Related]
43. Medical schools tackle conflict of interest. Catton M CMAJ; 2005 Nov; 173(10):1143. PubMed ID: 16275958 [No Abstract] [Full Text] [Related]
44. [Partnership between drug industry and the university--innovation, proof of efficacy, drug safety]. Weihrauch TR Z Gastroenterol; 1999 Jul; Suppl 2():12-8. PubMed ID: 10472694 [No Abstract] [Full Text] [Related]
45. Conflict of interest. Stung by controversy, biomedical groups urge consistent guidelines. Kaiser J Science; 2007 Jul; 317(5837):441. PubMed ID: 17656694 [No Abstract] [Full Text] [Related]
46. The nurse as principal investigator in a pharmaceutically sponsored drug trial: considerations and challenges. Rosenzweig MQ; Bender CM; Brufsky AM Oncol Nurs Forum; 2005 Mar; 32(2):293-9. PubMed ID: 15759067 [TBL] [Abstract][Full Text] [Related]
47. Leveraging the synergy between industry and academia. Bradley WG J Am Coll Radiol; 2005 Nov; 2(11):879-82. PubMed ID: 17411959 [No Abstract] [Full Text] [Related]
48. Conducting industry-partnered trials in orthopaedic surgery. Bhandari M; Jönsson A; Bühren V Injury; 2006 Apr; 37(4):361-6. PubMed ID: 16473356 [TBL] [Abstract][Full Text] [Related]
49. Clinical trials in India sponsored by the pharmaceutical industry: a proposal for reforms. Pai M; Colford JM Natl Med J India; 2002; 15(2):93-6. PubMed ID: 12044124 [No Abstract] [Full Text] [Related]
50. Conflicts of interest in dermatology. Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594 [TBL] [Abstract][Full Text] [Related]
51. Straight talk with... Charles Grassley. Interview by Meredith Wadman. Grassley C Nat Med; 2008 Oct; 14(10):1006-7. PubMed ID: 18841125 [No Abstract] [Full Text] [Related]
52. [Commercialization of the medical research is a reality. What is the limit?]. Naeser K Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105 [No Abstract] [Full Text] [Related]
54. Financial relationships between research and pharmaceutical/biotech companies: disclosure is imperative. Caughey AB; Urato AC Am J Obstet Gynecol; 2007 Jan; 196(1):e13; author reply e13-4; discussion e14. PubMed ID: 16959207 [No Abstract] [Full Text] [Related]
55. [Independent research should be supported]. Als-Nielsen B; Gluud C; Gluud LL Ugeskr Laeger; 2003 Oct; 165(44):4237; author reply 4237-8. PubMed ID: 14621563 [No Abstract] [Full Text] [Related]
56. The negotiation and development of a clinical trial agreement. Finn PB J Biolaw Bus; 2006; 9(2):21-7. PubMed ID: 17111523 [TBL] [Abstract][Full Text] [Related]
57. Conflict of interest in industry-sponsored drug development. Emanuel EJ Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285 [No Abstract] [Full Text] [Related]
58. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666 [TBL] [Abstract][Full Text] [Related]